Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro- Pt(IV) to circumvent cisplatin resistance

Journal of Inorganic Biochemistry

Volumn 77, Issue 1-2, 1999, Pages 65-70

  Siddik, Z H ^a   Hagopian, G S ^a   Thai, G ^a   Tomisaki, S ^a   Toyomasu, T ^a   Khokhar, A R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cisplatin; Drug resistance; p53; Toxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; CISPLATIN DERIVATIVE; PLATINUM 1,2 DIAMINOCYCLOHEXANEDIACETATE DICHLORIDE; PROTEIN P53; TETRAPLATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; DNA DAMAGE; DRUG RESISTANCE; DRUG STRUCTURE; LEUKEMIA CELL; MOUSE; NONHUMAN; OVARY TUMOR; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE;

CISPLATIN; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033367496     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00144-0     Document Type: Article

References (48)

1. Rosenberg B., Van Camp L., Trosko J.E., Mansour V.H. Nature (London). 222:1969;385-386.
2. Prestayko A.W., D'Aoust J.C., Issell B.F., Crooke S.T. Cancer Treat. Rev. 6:1979;17-39.
3. Von Hoff D.D., Rozencweig M. Adv. Pharmacol. Chemother. 16:1979;273-298.
4. J.R. Durant, in: A.W. Prestayko, T.S. Crooke, S.K. Carter (Eds.), Cisplatin, Current Status and New Developments, Academic Press, New York, 1980, pp. 317-332.
5. Loehrer P.J., Einhorn L.H. Ann. Intern. Med. 100:1984;704-713.
6. Pera M.F., Zook B.C., Harder H.C. Cancer Res. 39:1979;1269-1278.
7. Ozols R.F., Corden B.J., Jacob J., Wesley M.N., Otschega Y., Young R.C. Ann. Intern. Med. 100:1984;19-24.
8. R.F. Ozols, B.J. Corden, J. Collins, R.C. Young, in: P.M. Hacker, E. Douple, H.I. Krakoff (Eds.), Platinum Coordination Complexes in Cancer Chemotherapy, Martinus-Nijhoff Publishers, Boston, 1984, pp. 321-329.
9. Pfeifle C.E., Howell S.B., Felthouse R.D., Woliver T.B.S., Andrews P.A., Markman M., Murphy M.P. J. Clin. Oncol. 3:1985;237-244.
10. R.F. Borch, P.C. Bedon, A. Gringeri, T.J. Montine, in: M. Nicolini (Ed.), Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, Martinus-Nijhoff, Boston, 1988, pp. 207-215.
11. Calvert A.H., Harland S.J., Newell D.R., Siddik Z.H., Harrap K.R. Cancer Treat. Rev. (Suppl. A). 12:1985;51-57.
12. Harrap K.R. Cancer Treat. Rev. (Suppl. A). 12:1985;21-33.
13. Wiltshaw E. Cancer Treat. Rev. (Suppl. A). 12:1985;67-71.
14. Ozols R.F. Cancer Treat. Rev. (Suppl. A). 18:1991;77-83.
15. Ozols R.F. Hematol. Oncol. Clin. North Am. 6:1992;879-894.
16. Gore M.E., Levy V., Rustin G., Perren T., Calvert A.H., Earl H., Thompson J.M. Br. J. Cancer. 72:1995;1016-1019.
17. Kelland L.R. Critical Rev. Oncol. Hematol. 15:1993;191-219.
18. Timmer-Bosscha H., Mulder N.H., de Vries E.G.E. Br. J. Cancer. 66:1992;415-425.
19. R.F. Ozols, T.C. Hamilton, E. Reed, M.C. Poirier, H. Masuda, G. Lai, R.C. Young, in: M Nicolini (Ed.), Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, Martinus-Nijhoff, Boston, 1988, pp. 197-206.
20. Schilder R.J., Ozols R.F. Cancer Invest. 10:1992;307-315.
21. Burchenal J.H., Kalaher K., Dew K., Lokys L. Cancer Treat. Rep. 63:1979;1493-1498.
22. Kido Y., Khokhar A.R., Al-Baker S., Siddik Z.H. Cancer Res. 53:1993;4567-4572.
23. Blatter E.E., Vollano J.F., Krishnan B.S., Dabrowiak J.C. Biochemistry. 23:1984;4817-4820.
24. Eastman A. Biochem. Pharmacol. 36:1987;4177-4178.
25. Pendyala L., Arakali A.V., Sansone P., Cowens J.W., Creaven P.J. Cancer Chemother. Pharmacol. 27:1990;248-250.
26. Kido Y., Khokhar A.R., Siddik Z.H. Anti-Cancer Drugs. 4:1993;251-258.
27. Pendyala L., Kidani Y., Perez R., Wilkes J., Bernacki R.J., Creaven P.J. Cancer Lett. 97:1995;177-184.
28. Gibbons G.R., Wyrick S., Chaney S.G. Cancer Res. 49:1989;1402-1407.
29. Chaney S.G., Wyrick S., Till G.K. Cancer Res. 50:1990;4539-4545.
30. Behrens B.C., Hamilton T.C., Masuda H., Grotzinger K.R., Whang-Peng J., Louie K.G., Knutsen T., McCoy W.M., Young R.C., Ozols R.F. Cancer Res. 47:1987;414-418.
31. A. Eastman, N. Schulte, N. Sheibani, C.M. Sorenson, in: M. Nicolini (Ed.), Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, Martinus-Nijhoff, Boston, 1988, pp. 178-196.
32. Kelley S.L., Rozencweig M. Eur. J. Cancer Clin. Oncol. 25:1989;1135-1140.
33. Andrews P.A., Howell S.B. Cancer Cells. 2:1990;35-43.
34. Fink D., Nebel S., Aebi S., Zheng H., Cenni B., Nehme A., Christen R.D., Howell S.B. Cancer Res. 56:1996;4881-4886.
35. Johnson S.W., Laub P.B., Beesley J.S., Ozols R.F., Hamilton T.C. Cancer Res. 57:1997;850-856.
36. Teicher B.A., Holden S.A., Kelley M.J., Shea T.C., Cucchi C.A., Rosowsky A., Henner W.D., Frei III E. Cancer Res. 47:1987;388-393.
37. Richon V.M., Schulte N., Eastman A. Cancer Res. 47:1987;2056-2061.
38. Siddik Z.H., Mims B., Lozano G., Thai G. Cancer Res. 58:1998;698-703.
39. Hagopian G.S., Mills G.B., Khokhar A.R., Bast Jr R.C., Siddik Z.H. Clin. Cancer Res. 5:1999;655-663.
40. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Cancer Res. 51:1991;6304-6311.
41. Fritsche M., Haessler C., Bradner G. Oncogene. 8:1993;307-318.
42. Hartwell L.H., Kastan M.B. Science. 266:1994;1821-1828.
43. Fan S., Smith M.L., Rivet D.J., Duba D., Zhan Q., Kohn K.W., Fornace Jr A.J., O'Connor P.M. Cancer Res. 55:1995;1649-1654.
44. Hawkins D.S., Demers G.W., Galloway D.A. Cancer Res. 56:1996;892-898.
45. Ahnen D.J., Feigl P., Quan G., Fenoglio-Preiser C., Lovato L.C., Bunn Jr P.A., Stemmerman G., Wells J.D., Macdonald J.S., Meyskens Jr F.L Cancer Res. 58:1998;1149-1158.
46. Siddik Z.H., Al-Baker S., Thai G, Khokhar A.R. Anti-Cancer Drug Design. 9:1994;139-151.
47. Prestayko A.W., Bradner W.T., Huftalen J.B., Rose W.C., Schurig J.E., Cleare M.J., Hydes P.C., Crooke S.T. Cancer Treat. Rep. 63:1979;1503-1508.
48. Righetti S.C., Torre G.D., Pilotti S., Menard S., Ottone F., Colnaghi M.I., Pierotti M.A., Lavarino C., Cornarotti M., Oriana S., Bohm S., Bresciani G.L., Spatti G., Zunino F. Cancer Res. 56:1996;689-693.